These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 11107563

  • 1. [Emergency treatment of migraine attacks with particular reference to agonists of 5-HT1B/1D receptor].
    Prusiński A.
    Neurol Neurochir Pol; 1999; 32 Suppl 6():39-49. PubMed ID: 11107563
    [Abstract] [Full Text] [Related]

  • 2. Migraine headache.
    Morillo LE.
    Clin Evid; 2003 Dec; (10):1547-65. PubMed ID: 15555160
    [No Abstract] [Full Text] [Related]

  • 3. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP, Gawel M.
    Drugs; 2003 Dec; 63(21):2285-305. PubMed ID: 14524731
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Kayser V, Aubel B, Hamon M, Bourgoin S.
    Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacotherapy of headache with special reference to migraine].
    Beubler E.
    Wien Med Wochenschr; 1994 Dec; 144(5-6):100-1. PubMed ID: 8053212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Review of zolmitriptan and its clinical applications in migraine.
    Dowson AJ, Charlesworth B.
    Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
    [Abstract] [Full Text] [Related]

  • 10. New "triptans" and other drugs for migraine.
    Med Lett Drugs Ther; 1998 Oct 09; 40(1037):97-100. PubMed ID: 9793036
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of migraine in patients with hypertension and ischemic heart disease].
    Ficzere A, Csiba L.
    Ideggyogy Sz; 2002 Jan 20; 55(1-2):25-9. PubMed ID: 12122940
    [Abstract] [Full Text] [Related]

  • 14. Advances in pharmacological treatment of migraine.
    Diener HC, Limmroth V.
    Expert Opin Investig Drugs; 2001 Oct 20; 10(10):1831-45. PubMed ID: 11772289
    [Abstract] [Full Text] [Related]

  • 15. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D, Hanssens Y.
    Acta Neurol Belg; 1999 Jun 20; 99(2):85-95. PubMed ID: 10427351
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
    Dahlöf C, Maassen Van Den Brink A.
    Headache; 2012 Apr 20; 52(4):707-14. PubMed ID: 22444161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.